JP2012532601A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532601A5 JP2012532601A5 JP2012519119A JP2012519119A JP2012532601A5 JP 2012532601 A5 JP2012532601 A5 JP 2012532601A5 JP 2012519119 A JP2012519119 A JP 2012519119A JP 2012519119 A JP2012519119 A JP 2012519119A JP 2012532601 A5 JP2012532601 A5 JP 2012532601A5
- Authority
- JP
- Japan
- Prior art keywords
- factor
- clotting
- ctp
- coagulation
- coagulation factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims 41
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims 41
- 239000003114 blood coagulation factor Substances 0.000 claims 41
- 101800005309 Carboxy-terminal peptide Proteins 0.000 claims 26
- 210000004899 c-terminal region Anatomy 0.000 claims 11
- 229920001184 polypeptide Polymers 0.000 claims 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims 11
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims 9
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims 9
- 229940015047 chorionic gonadotropin Drugs 0.000 claims 9
- 102100022641 Coagulation factor IX Human genes 0.000 claims 7
- 108010076282 Factor IX Proteins 0.000 claims 7
- 229960004222 factor ix Drugs 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 239000002157 polynucleotide Substances 0.000 claims 7
- 102000040430 polynucleotide Human genes 0.000 claims 7
- 108091033319 polynucleotide Proteins 0.000 claims 7
- 102100023804 Coagulation factor VII Human genes 0.000 claims 6
- 108010023321 Factor VII Proteins 0.000 claims 6
- 108010054265 Factor VIIa Proteins 0.000 claims 6
- 229940012413 factor vii Drugs 0.000 claims 6
- 229940012414 factor viia Drugs 0.000 claims 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 102000006771 Gonadotropins Human genes 0.000 claims 4
- 108010086677 Gonadotropins Proteins 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 239000002622 gonadotropin Substances 0.000 claims 4
- 239000013604 expression vector Substances 0.000 claims 3
- 230000013595 glycosylation Effects 0.000 claims 2
- 238000006206 glycosylation reaction Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 208000031220 Hemophilia Diseases 0.000 claims 1
- 208000009292 Hemophilia A Diseases 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22436609P | 2009-07-09 | 2009-07-09 | |
| US61/224,366 | 2009-07-09 | ||
| PCT/IL2010/000532 WO2011004361A2 (en) | 2009-07-09 | 2010-07-01 | Long-acting coagulation factors and methods of producing same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015199912A Division JP6162769B2 (ja) | 2009-07-09 | 2015-10-08 | 長期作用性凝固因子およびそれを製造する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532601A JP2012532601A (ja) | 2012-12-20 |
| JP2012532601A5 true JP2012532601A5 (enExample) | 2013-05-16 |
| JP5823960B2 JP5823960B2 (ja) | 2015-11-25 |
Family
ID=43429620
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012519119A Active JP5823960B2 (ja) | 2009-07-09 | 2010-07-01 | 長期作用性凝固因子およびそれを製造する方法 |
| JP2015199912A Active JP6162769B2 (ja) | 2009-07-09 | 2015-10-08 | 長期作用性凝固因子およびそれを製造する方法 |
| JP2017117769A Active JP6430592B2 (ja) | 2009-07-09 | 2017-06-15 | 長期作用性凝固因子およびそれを製造する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015199912A Active JP6162769B2 (ja) | 2009-07-09 | 2015-10-08 | 長期作用性凝固因子およびそれを製造する方法 |
| JP2017117769A Active JP6430592B2 (ja) | 2009-07-09 | 2017-06-15 | 長期作用性凝固因子およびそれを製造する方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8476234B2 (enExample) |
| EP (2) | EP3130346A1 (enExample) |
| JP (3) | JP5823960B2 (enExample) |
| KR (3) | KR101950961B1 (enExample) |
| CN (2) | CN105153314B (enExample) |
| AU (1) | AU2010269884B2 (enExample) |
| CA (1) | CA2767503C (enExample) |
| CY (1) | CY1118733T1 (enExample) |
| DK (1) | DK2451473T3 (enExample) |
| ES (1) | ES2618209T3 (enExample) |
| HR (1) | HRP20170051T1 (enExample) |
| HU (1) | HUE032973T2 (enExample) |
| IL (2) | IL235377A (enExample) |
| LT (1) | LT2451473T (enExample) |
| MX (4) | MX386807B (enExample) |
| PL (1) | PL2451473T3 (enExample) |
| PT (1) | PT2451473T (enExample) |
| SI (1) | SI2451473T1 (enExample) |
| WO (1) | WO2011004361A2 (enExample) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7553941B2 (en) | 2006-02-03 | 2009-06-30 | Modigene Inc | Long-acting polypeptides and methods of producing same |
| US8946155B2 (en) | 2006-02-03 | 2015-02-03 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US8048849B2 (en) | 2006-02-03 | 2011-11-01 | Modigene, Inc. | Long-acting polypeptides and methods of producing same |
| US8304386B2 (en) * | 2006-02-03 | 2012-11-06 | Prolor Biotech, Inc. | Long-acting growth hormone and methods of producing same |
| US20140113860A1 (en) | 2006-02-03 | 2014-04-24 | Prolor Biotech Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US9458444B2 (en) | 2006-02-03 | 2016-10-04 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| US8476234B2 (en) * | 2006-02-03 | 2013-07-02 | Prolor Biotech Inc. | Long-acting coagulation factors and methods of producing same |
| US8759292B2 (en) | 2006-02-03 | 2014-06-24 | Prolor Biotech, Llc | Long-acting coagulation factors and methods of producing same |
| US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| US10351615B2 (en) | 2006-02-03 | 2019-07-16 | Opko Biologics Ltd. | Methods of treatment with long-acting growth hormone |
| US20150038413A1 (en) | 2006-02-03 | 2015-02-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US10221228B2 (en) | 2006-02-03 | 2019-03-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US8450269B2 (en) | 2006-02-03 | 2013-05-28 | Prolor Biotech Ltd. | Long-acting growth hormone and methods of producing same |
| US8546548B2 (en) | 2009-05-27 | 2013-10-01 | Baxter International Inc. | Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
| US9663778B2 (en) | 2009-07-09 | 2017-05-30 | OPKO Biologies Ltd. | Long-acting coagulation factors and methods of producing same |
| US12203113B2 (en) | 2009-07-09 | 2025-01-21 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2857499A1 (en) | 2010-10-01 | 2015-04-08 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| CA2831613A1 (en) | 2011-03-31 | 2012-10-04 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| PT3682905T (pt) | 2011-10-03 | 2022-04-07 | Modernatx Inc | Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações |
| TWI565715B (zh) | 2011-10-06 | 2017-01-11 | 韓美科學股份有限公司 | 凝血因子VII及VIIa之衍生物、接合物及含該接合物之複合物與其用途 |
| ES2923757T3 (es) | 2011-12-16 | 2022-09-30 | Modernatx Inc | Composiciones de ARNm modificado |
| PE20142290A1 (es) * | 2012-02-14 | 2015-01-15 | Opko Biolog Ltd | Factores de coagulacion de accion prolongada y metodos de produccion de los mismos |
| WO2013151664A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US10501512B2 (en) | 2012-04-02 | 2019-12-10 | Modernatx, Inc. | Modified polynucleotides |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| WO2013157002A1 (en) | 2012-04-19 | 2013-10-24 | Prolor Biotech Inc. | Long-acting oxyntomodulin variants and methods of producing same |
| WO2014018777A2 (en) * | 2012-07-25 | 2014-01-30 | Biogen Idec Ma Inc. | Blood factor monitoring assay and uses thereof |
| SG11201503879QA (en) * | 2012-11-20 | 2015-06-29 | Opko Biolog Ltd | Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides |
| PT2922554T (pt) | 2012-11-26 | 2022-06-28 | Modernatx Inc | Arn modificado nas porções terminais |
| EP2925345B1 (en) * | 2012-12-03 | 2018-09-05 | Merck Sharp & Dohme Corp. | Method for making o-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues |
| RS61387B2 (sr) | 2013-02-15 | 2024-06-28 | Bioverativ Therapeutics Inc | Gen optimizovanog faktora viii |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
| US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
| HUE050002T2 (hu) * | 2013-10-21 | 2020-11-30 | Opko Biologics Ltd | Hosszan ható polipeptidek és eljárás azok elõállítására és beadására |
| US11008561B2 (en) | 2014-06-30 | 2021-05-18 | Bioverativ Therapeutics Inc. | Optimized factor IX gene |
| KR102527180B1 (ko) * | 2014-12-10 | 2023-04-27 | 옵코 바이오로직스 리미티드 | 장기간 작용성 ctp-변형된 성장 호르몬 폴리펩타이드의 제조 방법 |
| KR102662956B1 (ko) | 2015-06-19 | 2024-05-03 | 옵코 바이오로직스 리미티드 | 장기-작용성 응고 인자 및 그의 제조 방법 |
| CN106397571A (zh) * | 2015-07-31 | 2017-02-15 | 李金松 | 一种新型羧基末端肽及长效白介素7 |
| CN106397570B (zh) * | 2015-07-31 | 2019-11-15 | 袁武梅 | 一种羧基末端肽及长效干扰素 |
| WO2017070167A1 (en) * | 2015-10-20 | 2017-04-27 | The University Of North Carolina At Chapel Hill | Methods and compositions for modified factor ix fusion proteins |
| KR20180118659A (ko) | 2016-02-01 | 2018-10-31 | 바이오버라티브 테라퓨틱스 인크. | 최적화된 viii 인자 유전자 |
| EP4303228B1 (en) * | 2016-07-11 | 2026-05-27 | OPKO Biologics Ltd. | Long-acting coagulation factor vii and methods of producing same |
| CN106279437B (zh) | 2016-08-19 | 2017-10-31 | 安源医药科技（上海）有限公司 | 高糖基化人凝血因子viii融合蛋白及其制备方法与用途 |
| CN107759697B (zh) * | 2016-08-19 | 2023-03-24 | 安源医药科技（上海）有限公司 | 制备融合蛋白的方法 |
| CN106279436B (zh) * | 2016-08-19 | 2017-10-31 | 安源医药科技（上海）有限公司 | 活化的人凝血因子vii融合蛋白及其制备方法与用途 |
| CN110438022A (zh) * | 2018-10-10 | 2019-11-12 | 福建师范大学 | 一种前体蛋白Kex2过表达毕赤酵母菌株及其构建方法 |
| ES3062513T3 (en) | 2019-03-19 | 2026-04-13 | CSL Innovation Pty Ltd | Factor ix variants and uses thereof in therapy |
| CN112175088B (zh) * | 2019-07-02 | 2023-03-28 | 江苏晟斯生物制药有限公司 | 改进的fix融合蛋白、缀合物及其应用 |
| JP7803014B2 (ja) | 2019-09-30 | 2026-01-21 | バイオベラティブ セラピューティクス インコーポレイテッド | レンチウイルスベクター製剤 |
| JP2023537565A (ja) | 2020-06-24 | 2023-09-04 | バイオベラティブ セラピューティクス インコーポレイテッド | タンパク質を発現するように改変されたレンチウイルスベクターの調製物から遊離第ｖｉｉｉ因子を除去する方法 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US130060A (en) * | 1872-07-30 | Improvement in cotton-presses | ||
| US190611A (en) * | 1877-05-08 | Improvement in protractors | ||
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| JPS5781447A (en) | 1980-11-11 | 1982-05-21 | Toyo Jozo Co Ltd | Human chorionic gonadotropic hormone c-terminal fragment |
| US4853332A (en) | 1982-10-19 | 1989-08-01 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| DE3421468A1 (de) | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| DE3751873T2 (de) | 1986-04-09 | 1997-02-13 | Genzyme Corp | Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| EP0374257B1 (en) | 1988-05-06 | 1994-08-31 | Toray Industries, Inc. | STABLE INTERFERON $g(b) COMPOSITION |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| DE122010000006I2 (de) | 1989-02-21 | 2012-06-21 | Univ Washington | Modifizierte formen von fortpflanzungshormonen. |
| US5705478A (en) | 1989-02-21 | 1998-01-06 | Washington University | Covalently linked β subunits of the glycoprotein hormones as antagonists |
| US6225449B1 (en) | 1991-10-04 | 2001-05-01 | Washington University | Hormone analogs with multiple CTP extensions |
| US5792460A (en) * | 1989-02-21 | 1998-08-11 | Washington University | Modified glycoprotein hormones having a CTP at the amino terminus |
| US5338835A (en) | 1989-02-21 | 1994-08-16 | Washington University | CTP-extended form of FSH |
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US7217689B1 (en) | 1989-10-13 | 2007-05-15 | Amgen Inc. | Glycosylation analogs of erythropoietin |
| US5126324A (en) | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
| US6028177A (en) | 1991-10-04 | 2000-02-22 | Washington University | Methods of detecting single-chain forms of the glycoprotein hormone quartet |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| CA2160800C (en) | 1993-04-20 | 2010-06-01 | Irving Boime | Ctp modified gonadotropic proteins |
| US6737515B2 (en) | 1993-11-19 | 2004-05-18 | Washington University | Follicle stimulating hormone-glycosylation analogs |
| US6238890B1 (en) | 1994-02-18 | 2001-05-29 | Washington University | Single chain forms of the glycoprotein hormone quartet |
| US5935924A (en) | 1994-04-15 | 1999-08-10 | Genentech, Inc. | Treatment of congestive heart failure |
| US5541110A (en) | 1994-05-17 | 1996-07-30 | Bristol-Myers Squibb | Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica |
| BR9506313A (pt) | 1994-08-12 | 1997-08-05 | Univ Washington | Formas de cadeia simples do quarteto de hormônio de glicoproteína |
| US6083725A (en) | 1996-09-13 | 2000-07-04 | Transkaryotic Therapies, Inc. | Tranfected human cells expressing human α-galactosidase A protein |
| US20050032211A1 (en) | 1996-09-26 | 2005-02-10 | Metabogal Ltd. | Cell/tissue culturing device, system and method |
| US6310183B1 (en) | 1997-09-10 | 2001-10-30 | Novo Nordisk A/S | Coagulation factor VIIa composition |
| AU766190B2 (en) | 1998-10-16 | 2003-10-09 | Biogen Idec Ma Inc. | Interferon-beta fusion proteins and uses |
| US6514729B1 (en) | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
| PE20010288A1 (es) | 1999-07-02 | 2001-03-07 | Hoffmann La Roche | Derivados de eritropoyetina |
| US20020127652A1 (en) * | 2000-02-11 | 2002-09-12 | Schambye Hans Thalsgard | Follicle stimulating hormones |
| US7094566B2 (en) | 2000-03-16 | 2006-08-22 | Amgen Inc., | IL-17 receptor like molecules and uses thereof |
| WO2002043709A1 (fr) | 2000-12-01 | 2002-06-06 | Takeda Chemical Industries, Ltd. | Procede de production d'une preparation contenant une substance bioactive |
| JP4409135B2 (ja) | 2000-12-01 | 2010-02-03 | 武田薬品工業株式会社 | 生理活性物質含有製剤の製造法 |
| SI1724284T1 (sl) | 2000-12-07 | 2009-12-31 | Lilly Co Eli | Glp-1 fuzijski proteini |
| KR101229995B1 (ko) | 2000-12-11 | 2013-02-06 | 씨제이 주식회사 | 생체내 에리스로포이에틴 활성이 증진된 융합단백질 |
| EP1342730B1 (en) | 2000-12-11 | 2006-03-15 | Cheil Jedang Corporation | Fusion protein having the enhanced in vivo activity of erythropoietin |
| JP5160005B2 (ja) | 2000-12-28 | 2013-03-13 | 武田薬品工業株式会社 | 徐放性製剤 |
| EP1356809A4 (en) | 2000-12-28 | 2008-05-14 | Takeda Pharmaceutical | Sustained release preparations |
| US6887462B2 (en) | 2001-04-09 | 2005-05-03 | Chiron Corporation | HSA-free formulations of interferon-beta |
| GB0121709D0 (en) | 2001-09-07 | 2001-10-31 | Imp College Innovations Ltd | Food inhibition agent |
| CA2841097A1 (en) | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin and g-csf fusion proteins |
| US7081446B2 (en) | 2002-01-31 | 2006-07-25 | The Trustees Of Columbia University In The City Of New York | Long-acting follicle stimulating hormone analogues and uses thereof |
| US7173113B2 (en) | 2002-01-31 | 2007-02-06 | The Trustees Of Columbia University In The City Of New York | Long-acting hormone and growth factor compositions and uses thereof |
| GB0206048D0 (en) | 2002-03-14 | 2002-04-24 | Croda Int Plc | Use |
| US7459435B2 (en) | 2002-08-29 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| US7459436B2 (en) | 2002-11-22 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| JP4683319B2 (ja) | 2003-02-19 | 2011-05-18 | 武田薬品工業株式会社 | 徐放性製剤用の分散剤 |
| EP1595549A4 (en) | 2003-02-19 | 2010-09-22 | Takeda Pharmaceutical | DISPERSE FOR PREPARATIONS WITH DELAYED RELEASE |
| US7649084B2 (en) | 2003-11-12 | 2010-01-19 | University Of Georgia Research Foundation, Inc. | Recombinant glycoproteins related to feline thyrotropin |
| PL1696947T3 (pl) | 2003-12-19 | 2014-08-29 | Hoffmann La Roche | Zastosowanie erytropoetyny w leczeniu zaburzeń dystrybucji żelaza w przewlekłych chorobach zapalnych jelit |
| WO2005094873A1 (en) | 2004-03-19 | 2005-10-13 | Baxter International Inc. | Factor ixa for the treatment of bleeding disorders |
| RU2396347C2 (ru) | 2004-08-17 | 2010-08-10 | Ксл Бехринг Гмбх | Модифицированные витамин к-зависимые полипептиды |
| EP1728798A1 (en) | 2005-06-01 | 2006-12-06 | ZLB Behring GmbH | Coagulation factor X polypeptides with modified activation properties |
| US8476234B2 (en) * | 2006-02-03 | 2013-07-02 | Prolor Biotech Inc. | Long-acting coagulation factors and methods of producing same |
| US7553941B2 (en) | 2006-02-03 | 2009-06-30 | Modigene Inc | Long-acting polypeptides and methods of producing same |
| US8048849B2 (en) | 2006-02-03 | 2011-11-01 | Modigene, Inc. | Long-acting polypeptides and methods of producing same |
| US8048848B2 (en) | 2006-02-03 | 2011-11-01 | Prolor Biotech Ltd. | Long-acting interferons and derivatives thereof and methods thereof |
| US8304386B2 (en) | 2006-02-03 | 2012-11-06 | Prolor Biotech, Inc. | Long-acting growth hormone and methods of producing same |
-
2010
- 2010-06-30 US US12/826,754 patent/US8476234B2/en active Active
- 2010-07-01 ES ES10796803.4T patent/ES2618209T3/es active Active
- 2010-07-01 LT LTEP10796803.4T patent/LT2451473T/lt unknown
- 2010-07-01 PT PT107968034T patent/PT2451473T/pt unknown
- 2010-07-01 JP JP2012519119A patent/JP5823960B2/ja active Active
- 2010-07-01 KR KR1020177033906A patent/KR101950961B1/ko active Active
- 2010-07-01 MX MX2017002687A patent/MX386807B/es unknown
- 2010-07-01 DK DK10796803.4T patent/DK2451473T3/en active
- 2010-07-01 KR KR1020127003469A patent/KR101802919B1/ko active Active
- 2010-07-01 EP EP16187710.5A patent/EP3130346A1/en not_active Ceased
- 2010-07-01 HU HUE10796803A patent/HUE032973T2/en unknown
- 2010-07-01 CA CA2767503A patent/CA2767503C/en active Active
- 2010-07-01 WO PCT/IL2010/000532 patent/WO2011004361A2/en not_active Ceased
- 2010-07-01 KR KR1020197004563A patent/KR102014844B1/ko active Active
- 2010-07-01 PL PL10796803T patent/PL2451473T3/pl unknown
- 2010-07-01 CN CN201510572447.0A patent/CN105153314B/zh active Active
- 2010-07-01 MX MX2014010834A patent/MX346920B/es unknown
- 2010-07-01 HR HRP20170051TT patent/HRP20170051T1/hr unknown
- 2010-07-01 SI SI201031374A patent/SI2451473T1/sl unknown
- 2010-07-01 EP EP10796803.4A patent/EP2451473B1/en active Active
- 2010-07-01 CN CN201080040296.XA patent/CN102639144B/zh active Active
- 2010-07-01 AU AU2010269884A patent/AU2010269884B2/en active Active
- 2010-07-01 MX MX2012000469A patent/MX2012000469A/es active IP Right Grant
-
2012
- 2012-01-09 MX MX2021012106A patent/MX2021012106A/es unknown
-
2014
- 2014-10-28 IL IL235377A patent/IL235377A/en active IP Right Grant
-
2015
- 2015-10-08 JP JP2015199912A patent/JP6162769B2/ja active Active
- 2015-10-29 IL IL242368A patent/IL242368B/en active IP Right Grant
-
2017
- 2017-01-17 CY CY20171100062T patent/CY1118733T1/el unknown
- 2017-06-15 JP JP2017117769A patent/JP6430592B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chow et al. | Peptide-based biopolymers in biomedicine and biotechnology | |
| JP2009268467A5 (enExample) | ||
| JP2016501198A5 (enExample) | ||
| HRP20170051T1 (hr) | Dugodjelujući faktori koagulacije i postupci za njihovu proizvodnju | |
| JP2012504965A5 (enExample) | ||
| HRP20200871T1 (hr) | Izmjenjeni rsv f proteini i postupci njihove uporabe | |
| JP2018537087A5 (enExample) | ||
| JP2013538864A5 (enExample) | ||
| JP2012530504A5 (enExample) | ||
| JP2010529860A5 (enExample) | ||
| JP2005509609A5 (enExample) | ||
| JP2014521684A5 (enExample) | ||
| JP2005516885A5 (enExample) | ||
| JP2008503217A5 (enExample) | ||
| JP2017160222A5 (enExample) | ||
| JP2013027391A5 (enExample) | ||
| JP2005120106A5 (enExample) | ||
| CN106928320B (zh) | 一种合成Etelcalcetide的方法 | |
| JP2015212284A5 (enExample) | ||
| JP2014508510A5 (enExample) | ||
| JP2010512160A5 (enExample) | ||
| JP2015524403A5 (enExample) | ||
| JP2014525439A5 (enExample) | ||
| JP2014504297A5 (enExample) | ||
| JP2016508143A5 (enExample) |